Showing 41-50 of 834 results for "".
Case Studies in Treating Ocular Surface Disease: Season 3
https://modernod.com/podcasts/the-mod-pod/case-studies-in-treating-ocular-surface-disease-season-3-mod/36823/Join this season’s new expert panel of Cecelia Koetting, OD; Walt Whitley, OD; and Marjan Farid, MD, as they deliberate on a myriad of interesting cases across the ocular surface spectrum.Referral Network Breakdown
https://modernod.com/mod-issues/2019-mar/referral-network-breakdown/39052/The two most common types of communication issues between collaborating ODs and MDs and how to set them straight.Modern Management of Vitreous Opacities: Surgical Considerations
https://modernod.com/podcasts/the-mod-pod/vitreous-opacities-surgical-considerations/36821/How have innovations in surgical instrumentation created an environment in which surgeons are more comfortable performing vitrectomy for vitreous opacities? In the final episode of the miniseries “Modern Management of Vitreous Opacities,” a panel comprised of Walt Whitley, OD, MBA; Alison Early, MD;Modern Management of Vitreous Opacities: Examination and Referral
https://modernod.com/podcasts/the-mod-pod/vitreous-opacities-examination-and-referral/36820/Which elements of examination must optometrists perfect in order to provide an effective referral for patients with vitreous opacities? On this second episode of the miniseries “Modern Management of Vitreous Opacities,” the panel comprised of Walt Whitley, OD, MBA; Alison Early, MD; John Kitchens, MRetina Specialist Perspectives
https://modernod.com/specialty/retina/Retina-Specialist-Perspectives-2506/33191/Retina specialists share collaborative care strategies to achieve the best outcomes for patients with retinal disease. <Overcoming Treatment Plateaus in Chronic DME
https://modernod.com/specialty/retina/Overcoming-Treatment-Plateaus-in-Chronic-DME-2506/33190/Learn about a patient with a 9-year history of injections for treatment of retinal disease and the final approach resulting in positive outcomes.[Genetics and Eyecare Today] How CXL and Genetic Testing Fit Into the Keratoconus Game Plan
https://modernod.com/podcasts/the-mod-pod/genetics-and-eyecare-today-how-cxl-and-genetic-testing-fit-into-the-keratoconus-game-plan/36816/The season finale of The MOD Pod’s mini series Genetics and Eyecare Today features Nicole Fram, MD, and Melissa Barnett, OD, FAAO, FSLS, FBCLA. Dr. Fram explains what corneal collagen crosslinking is and shares her protocol for administering the therapy. She also describes the typical situation in wFirst Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesFirst Robotic Cataract Surgery Performed
https://modernod.com/podcasts/eyewire-news-the-podcast/first-robotic-cataract-surgery-performed/39875/Uday Devgan, MD, shares his experience performing the world’s first robotic cataract surgery; Konan Medical receives CE Mark for its objectiveFIELD Analyzer perimetry device; and Biotech Healthcare launches a new full visual range EDOF IOL. Learn more about your ad choices. Visit megaphone.fm/adchoAlcon Acquires LumiThera
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-lumithera/37092/Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management. Learn more about your ad choices. Visit megaphone.fm/adchoices